The Cochrane Database of Systematic Reviews 2003
DOI: 10.1002/14651858.cd001186
|View full text |Cite
|
Sign up to set email alerts
|

Allergen immunotherapy for asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
204
2
28

Year Published

2003
2003
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 325 publications
(242 citation statements)
references
References 172 publications
5
204
2
28
Order By: Relevance
“…Immunotherapy should not be regarded as an alternative to established forms of preventive therapy. Numerous studies have been conducted to explore the role of immunotherapy in asthma (Abramson et al, 2010). The comparison was difficult because of the inherent problems of trials involving asthma, different allergen extract and dosage regimens.…”
Section: Immunotherapy In Asthmamentioning
confidence: 99%
“…Immunotherapy should not be regarded as an alternative to established forms of preventive therapy. Numerous studies have been conducted to explore the role of immunotherapy in asthma (Abramson et al, 2010). The comparison was difficult because of the inherent problems of trials involving asthma, different allergen extract and dosage regimens.…”
Section: Immunotherapy In Asthmamentioning
confidence: 99%
“…A limited number of AIT studies performed in Europe with extracts of Cladosporium and Alternaria have demonstrated therapeutic efficacy [15]. Cochrane reviews included just 2 out of 88 AIT trials with Cladosporium in its meta-analysis [29][30][31]. There has been acceptable evidence showing Alternaria SCIT is beneficial in allergic children and improves medication scores, combined symptom-medication scores, and quality of life in the patients [32].…”
Section: Limitations To Immunotherapymentioning
confidence: 99%
“…Allergen specific immunotherapy is effective and well tolerated treatment for allergic diseases. Allergen specific immunotherapy modifies the immunological response to allergens and induce a state of clinical tolerance [28][29][30]. SCIT was a safe treatment with a low risk to elicit severe systemic reaction, in which no fatality was observed.…”
Section: Diagnosis and Treatmentmentioning
confidence: 99%